Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check3 days agoChange DetectedThe Record History now shows the latest revision as v3.6.2 and removes the previous v3.6.0 entry, updating the page's version label.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study history now includes a new revision labeled v3.6.0 with the recruitment status updated to not currently recruiting participants. The previous revision entry v3.5.5 appears to have been removed from the history.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page history shows a newer revision version, updating from v3.5.4 to v3.5.5, indicating a small metadata update to the page history rather than a change to core study information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision label was updated to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor system/version change for the record history interface.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision entry added: v3.5.2. Previous entry v3.5.0 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.